From guidance to practice: Why NICE is not enough

被引：30
作者：
Dent, THS
Sadler, M
机构：
[1] N & Mid Hampshire Hlth Author, Basingstoke RG24 9NB, Hants, England
[2] NHS Direct Hampshire & Isle of Wight, Winchester SO22 5DH, Hants, England
来源：
BRITISH MEDICAL JOURNAL | 2002年 / 324卷 / 7341期
关键词：
D O I：
10.1136/bmj.324.7341.842
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：842 / 845
页数：4
相关论文
共 18 条
[11]  
PAYNE N, 1999, CONTROLLING COSTS ST, P118
[12]  
PITT FA, 1997, USE DONEPEZIL TREATM
[13]  
*ROYAL COLL PHYS L, 2000, PRESCR COSTL MED
[14]   Effectiveness, efficiency, and NICE - A NICE start but evidence costs money [J].
Sculpher, M ;
Drummond, M ;
O'Brien, B .
BRITISH MEDICAL JOURNAL, 2001, 322 (7292) :943-944
[15]   The failings of NICE - Time to start work on version 2 [J].
Smith, R .
BRITISH MEDICAL JOURNAL, 2000, 321 (7273) :1363-1364
[16]  
STEIN K, 1997, 69 DEC NHS EX S W
[17]   An integrated national pharmaceutical policy for the United Kingdom? [J].
Walley, T ;
Earl-Slater, A ;
Haycox, A ;
Bagust, A .
BRITISH MEDICAL JOURNAL, 2000, 321 (7275) :1523-1526
[18]  
2001, DRUG THER B, V39, P9
12